NCT06663501

Brief Summary

The aim of this study is to evaluate how vibration of the tendons enhances arm and hand training in survivors of chronic stroke. The investigators hypothesize that wrist/elbow robotic training, combined with body awareness training will improve arm and hand function in individuals with chronic stroke.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable stroke

Timeline
22mo left

Started Oct 2024

Longer than P75 for not_applicable stroke

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress48%
Oct 2024Mar 2028

Study Start

First participant enrolled

October 1, 2024

Completed
24 days until next milestone

First Submitted

Initial submission to the registry

October 25, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

October 29, 2024

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2027

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2028

Last Updated

March 20, 2026

Status Verified

March 1, 2026

Enrollment Period

2.4 years

First QC Date

October 25, 2024

Last Update Submit

March 18, 2026

Conditions

Keywords

Upper extremityAMESProprioceptionVibration

Outcome Measures

Primary Outcomes (1)

  • Change in Fugl-Meyer Assessment for the upper extremity score

    The Fugl-Meyer Assessment for the upper extremity measures the severity of injury following a stroke. The assessment is scored from 0-66 points. A higher score indicates less impairment

    1 day following intervention

Secondary Outcomes (3)

  • Proprioception Assessment

    1 day following intervention

  • Modified Ashworth Score

    1 day following intervention

  • Strength Assessment

    1 day following intervention

Study Arms (2)

Stroke Intervention

EXPERIMENTAL

In this arm, the participant will be scheduled to come to the laboratory 2-4 times per week and spend 30 minutes using the Assisted Motion with Enhanced Sensation (AMES) treatment device on the affected side of the upper limb.

Device: Assisted Motion with Enhanced Sensation training

Uninjured Control Intervention

ACTIVE COMPARATOR

In this arm the uninjured controls will perform the same interventions as the stroke group. The uninjured control group will perform the tests and interventions with their dominant arm/hand.

Device: Assisted Motion with Enhanced Sensation training

Interventions

During the AMES intervention, the AMES device will flex or extend the wrist/hand joint, and the participant's task will be to assist this motion. As the wrist/hand joint moves, the machine will be delivering a vibratory mechanical stimulus on the opposite side to the direction of movement. The activity of the muscles during the movement of the wrist/hand joint will be recorded by the device and it will be shown on a screen to be used as feedback during the training

Also known as: AMES Training
Stroke InterventionUninjured Control Intervention

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • If stroke, more than 6 months after
  • Medically stable
  • Not currently taking any anti-spasticity medications (for at least 2 weeks)
  • Able to comply with study requirements

You may not qualify if:

  • Recent change in the use of any medications
  • Other physical conditions such as orthopedic injuries or surgeries
  • Unstable Medical conditions or any other clinical observations that may affect the candidates performance, health, safety, or ability to participate in the study as determined by the treating therapist
  • Anti-spasticity drug injection in the 3 months prior to participation
  • Presence of significant cardiorespiratory or metabolic disease
  • Inability to achieve standard position required for EMG recordings
  • Intrathecal baclofen pump
  • Musculoskeletal conditions/surgeries resulting in difficulty participating
  • Adults unable to consent
  • Pregnant women, prisoners, and individuals under the age of 18

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shirley Ryan AbilityLab

Chicago, Illinois, 60611, United States

Location

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • William Z Rymer, PhD

    Shirley Ryan AbilityLab

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Single-site exploratory, unrandomized, the first arm is persons with stroke, the second arm is uninjured controls. Both Cohorts receive the same intervention
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director Single Motor Unit Laboratory

Study Record Dates

First Submitted

October 25, 2024

First Posted

October 29, 2024

Study Start

October 1, 2024

Primary Completion (Estimated)

March 1, 2027

Study Completion (Estimated)

March 1, 2028

Last Updated

March 20, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations